Immunochromatographic rapid test for the quantitative determination of Cancer Antigen 19-9 (CA 19-9) in whole blood, serum or plasma. Measuring range: 30-1000 U/mL. Reading time: 15 minutes.
Manufactured by
Alencon, France
VEDALAB is a privately French owned company, founded in 1991 It is devoted to the development, production and marketing of in vitro immunodiagnostic reagents. As a market leader, VEDALAB focuses on international expansion by forming long-term partnerships with reliable and trustworthy distributors worldwide. Continually expanding its impressive range of products, VEDALAB is today the biggest rapid test manufacturer in Europe. VEDALAB s headquarters, its research and development, manufacturing and marketing departments are all located in a modern, well-equipped and expanding (4 500 m²) ISO certified plant in the beautiful Normandy town of Alençon. VEDALAB employs about 50 people all of whom are dedicated to the design, development, manufacture or promotion of a very wide range of innovative reagents and instruments, including the use of patented technologies. Throughout its years of development, VEDALAB has acquired incomparable research experience ranging from initial antibody screening to the creation of its own manufacturing equipment. Such unparalleled experience has made VEDALAB a reference of quality in the world of immunodiagnostics.
✦ Product-Specific Coverage
Based on AI-matched alternatives related to this product across Suplivia's medical sourcing network.
Generated for this product
AI-matched supplier coverage based on related product alternatives.
Anbio Biotechnology Limited
Germany · 4 relevant products
Medix Biochemica Oy AB
Finland · 6 relevant products
Nanjing Poclight Biotechnology Co.,Ltd.
China · 5 relevant products
J. Mitra & Co. Pvt. Ltd.
India · 2 relevant products
Boditech Med Inc.
South Korea · 4 relevant products
BiosPacific
United States · 2 relevant products
HeavyBio, Inc
China · 9 relevant products
Institute of Isotopes Co. Ltd.
Hungary · 1 relevant product
Fujirebio Diagnostics,Inc.
China · 6 relevant products
MedLevensohn
Brazil · 3 relevant products
41 more relevant manufacturers available
Get free access to all relevant manufacturers for this product.
See all manufacturers →3 more sourcing countries available
Get free access to all sourcing countries identified for this product.
See all countries →See the full supplier coverage for this product
Get free access to all relevant manufacturers, sourcing countries, and product alternatives.
✓ Free for medical industry professionals.
from other manufacturers
from other manufacturers
12 of 90 closest product alternatives
Anbio Biotechnology Limited · Germany
Immunoassay for carbohydrate antigen 19-9 measurement in clinical specimens. Supports pancreatic and biliary cancer monitoring.
Medix Biochemica Oy AB · Finland
A diagnostic test for measuring Cancer Antigen 19-9 (CA19-9) levels in blood samples. This test is used in clinical laboratories for cancer screening and monitoring, particularly for gastrointestinal cancers.
Nanjing Poclight Biotechnology Co.,Ltd. · China
An in vitro quantitative test kit using homogeneous chemiluminescence immunoassay for determination of Carbohydrate Antigen 19-9 in human serum and plasma. The test is used as an aid in the diagnosis of pancreatic cancer. For professional and laboratory use only, with 18 months shelf life and storage at 2-30°C without cold chain requirement.
J. Mitra & Co. Pvt. Ltd. · India
Tumor marker assay kit for CA19-9 detection using chemiluminescence immunoassay. Analytical sensitivity of 1.50 U/mL with linearity from 1.50 to 1000 U/mL.
Boditech Med Inc. · South Korea
A diagnostic test reagent that supports the diagnosis of pancreatic cancer.
BiosPacific · United States
High-quality antibodies for CA19-9 cancer marker detection and immunoassay development. Essential for pancreatic and gastrointestinal cancer diagnostics.
HeavyBio, Inc · China
Humanized antibody for CA19-9 detection in FIA/CLIA applications. Used as a gastrointestinal tract-associated tumor marker with high sensitivity and good specificity for pancreatic cancer diagnosis and monitoring.
Institute of Isotopes Co. Ltd. · Hungary
CA19-9 is a tumour associated mucin-type high molecular weight glycoprotein antigen circulating in the blood and can be found in tissues. This test is useful in monitoring patients with confirmed pancreatic cancer whose CA19-9 levels are above the cut off at the time of the diagnosis. Patients negative for the Lewis blood group antigen have no CA 19-9 in their blood even in the presence of malignant disease.
Fujirebio Diagnostics,Inc. · China
An in vitro diagnostic test kit for the detection of cancer antigen 19-9 (CA19-9), a tumor marker. The product is CE certified and complies with European in vitro diagnostic product directive 98/79/EC. It is manufactured by ISO13485 certified facilities in Gothenburg, Sweden and Malvern, Pennsylvania, USA.
HeavyBio, Inc · China
Mouse antibody for CA19-9 capture in FIA/CLIA applications. Detects tumor marker associated with pancreatic cancer, gallbladder cancer, colon cancer, and gastric cancer.
Medix Biochemica Oy AB · Finland
A diagnostic test for measuring Cancer Antigen 15-3 (CA15-3) levels in blood samples. This test is used in clinical laboratories for assessment and monitoring of breast cancer.
Medix Biochemica Oy AB · Finland
A diagnostic test for measuring Cancer Antigen 242 (CA242) levels in blood samples. This test is used in clinical laboratories for cancer assessment and monitoring.
78 more product alternatives available
Create a free account to compare more product alternatives and supplier options.
© 2026 Suplivia · Home · Browse Products